Pint Pharma is a biopharmaceutical company that specialises in the commercialisation of innovative therapies with the potential to transform outcomes in cancer, rare disease and other patient communities across the Latin American region. By collaborating with world-class biotech and pharma companies, Pint Pharma is committed to improving the lives of Latin American patients in areas of significant unmet medical need. The company is headquartered in Europe and counts with over 250 employees across its territories in Latin America including Brazil, Mexico, Argentina, Colombia, Chile, Peru and Ecuador.
Company Details
- Employees
- 248
- Address
- Vienna, At
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- pint-pharma.com
- Keywords
- Haematology, Immunology, Oncology, Genetic disorders, Rare Diseases, Orphan Drugs, Biotechnologies, Pharmaceuticals, Healthcare, Latin America.
- HQ
- Vienna
Pint Pharma Questions
Pint Pharma's website is pint-pharma.com
Pint Pharma's LinkedIn profile is https://at.linkedin.com/company/pint-pharma
Pint Pharma has
248 employees.
View email and phone details for 248
employees at Pint Pharma.
Pint Pharma's industry is
Pharmaceutical Manufacturing
Pint Pharma's top competitors are
Knight Therapeutics Brasil,
Gsk,
Sanofi,
Azistia,
Pfizer,
Roche,
Knight Therapeutics Argentina,
Astrazeneca,
Novartis,
Pharmexx Argentina.
Pint Pharma's categories are Pharmaceutical Manufacturing
